Debesh Mandal

Debesh Mandal is a biopharma entrepreneur with a strong foundation in computational biophysics and materials research. He is the Co-founder and CEO of Nanograb (YC S23), a company developing AI-generated binders for targeted drug delivery to address the issue of drug specificity and side effects. co+2

His academic background includes a PhD from Imperial College London in Materials Research, specializing in computational biophysics. His doctoral work involved advanced in silico modeling of polymer-based drug delivery systems, utilizing techniques like Langevin Dynamics, ReaDDy simulations, and developing Python software packages for research. co+1

Debesh has a strong technical skillset, particularly in programming and scientific computing. He is proficient in Python (advanced), LaTeX (advanced), and has intermediate skills in NodeJS, HTML/CSS/JS, C++, and React, which he applied in developing full-stack web applications for Nanograb and internal GUI tools at FabricNano. co+1

Beyond his current venture, Debesh has prior entrepreneurial experience as a co-founder of IRIS. Drone Technologies, a startup focused on using drones for healthcare material transport in developing markets. This role included serving as Managing Director/CTO. co+1

He has also contributed to academia as a Graduate Teaching Assistant at Imperial College London, where he supervised masters' projects and developed Python programming courses, demonstrating a commitment to education and mentorship in scientific fields. co